<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">BMC Psychiatry</journal-id>
<journal-id journal-id-type="iso-abbrev">BMC Psychiatry</journal-id>
<journal-title-group>
<journal-title>BMC Psychiatry</journal-title>
</journal-title-group>
<issn pub-type="epub">1471-244X</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27782808</article-id>
<article-id pub-id-type="pmc">5080712</article-id>
<article-id pub-id-type="publisher-id">1072</article-id>
<article-id pub-id-type="doi">10.1186/s12888-016-1072-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Study Protocol</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>COMPULS: design of a multicenter phenotypic, cognitive, genetic, and magnetic resonance imaging study in children with compulsive syndromes</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Naaijen</surname>
<given-names>Jilly</given-names>
</name>
<address>
<phone>+31 24 3610986</phone>
<email>j.naaijen@donders.ru.nl</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>de Ruiter</surname>
<given-names>Saskia</given-names>
</name>
<address>
<email>s.deruiter@karakter.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zwiers</surname>
<given-names>Marcel P.</given-names>
</name>
<address>
<email>m.zwiers@donders.ru.nl</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Glennon</surname>
<given-names>Jeffrey C.</given-names>
</name>
<address>
<email>j.glennon@donders.ru.nl</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Durston</surname>
<given-names>Sarah</given-names>
</name>
<address>
<email>S.Durston@umcutrecht.nl</email>
</address>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Lythgoe</surname>
<given-names>David J.</given-names>
</name>
<address>
<email>david.lythgoe@kcl.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Williams</surname>
<given-names>Steven C. R.</given-names>
</name>
<address>
<email>steve.williams@kcl.ac.uk</email>
</address>
<xref ref-type="aff" rid="Aff4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Banaschewski</surname>
<given-names>Tobias</given-names>
</name>
<address>
<email>tobias.banaschewski@zi-mannheim.de</email>
</address>
<xref ref-type="aff" rid="Aff5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Brandeis</surname>
<given-names>Daniel</given-names>
</name>
<address>
<email>daniel.brandeis@zi-mannheim.de</email>
</address>
<xref ref-type="aff" rid="Aff5">5</xref>
<xref ref-type="aff" rid="Aff6">6</xref>
<xref ref-type="aff" rid="Aff7">7</xref>
<xref ref-type="aff" rid="Aff8">8</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Franke</surname>
<given-names>Barbara</given-names>
</name>
<address>
<email>barbara.franke@radboudumc.nl</email>
</address>
<xref ref-type="aff" rid="Aff9">9</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Buitelaar</surname>
<given-names>Jan K.</given-names>
</name>
<address>
<email>jan.buitelaar@radboudumc.nl</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<aff id="Aff1"><label>1</label>Department of Cognitive Neuroscience, Donders Institute of Brain, Cognition and Behaviour, Radboud University Medical Center, Geert Grooteplein Noord 10 (Huispost 126), 6525 EZ Nijmegen, The Netherlands </aff>
<aff id="Aff2"><label>2</label>Karakter child and adolescent psychiatry university center, Nijmegen, The Netherlands </aff>
<aff id="Aff3"><label>3</label>NICHE lab, department of psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands </aff>
<aff id="Aff4"><label>4</label>Department of Neuroimaging, King’s College London, Institute of Psychiatry, Psychology and Neuroscience, London, UK </aff>
<aff id="Aff5"><label>5</label>Department of Child and Adolescent Psychiatry and Psychotherapy, Central Institute of Mental Health, Medical Faculty, Mannheim/Heidelberg University, Mannheim, Germany </aff>
<aff id="Aff6"><label>6</label>Department of Child and Adolescent Psychiatry, University of Zurich, Zurich, Switzerland </aff>
<aff id="Aff7"><label>7</label>Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland </aff>
<aff id="Aff8"><label>8</label>Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland </aff>
<aff id="Aff9"><label>9</label>Departments of Human Genetics and Psychiatry, Donders Institute of Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>26</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>26</day>
<month>10</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<year>2016</year>
</pub-date>
<volume>16</volume>
<elocation-id>361</elocation-id>
<history>
<date date-type="received">
<day>3</day>
<month>5</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>14</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2016</copyright-statement>
<license license-type="OpenAccess">
<license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<sec>
<title>Background</title>
<p>Compulsivity, the closely linked trait impulsivity and addictive behaviour are associated with several neurodevelopmental disorders, including attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and obsessive compulsive disorder (OCD). All three disorders show impaired fronto-striatal functioning, which may be related to altered glutamatergic signalling. Genetic factors are also thought to play an important role in the aetiology of compulsivity-related disorders.</p>
</sec>
<sec>
<title>Methods</title>
<p>The COMPULS study is a multi-center study designed to investigate the relationship between the traits compulsivity, impulsivity, and, to a lesser extent, addictive behaviour within and across the neurodevelopmental disorders ADHD, ASD, and OCD. This will be done at the phenotypic, cognitive, neural, and genetic level. In total, 240 participants will take part in COMPULS across four different sites in Europe. Data collection will include diagnostic interviews, behavioural questionnaires, cognitive measures, structural, functional and spectral neuroimaging, and genome-wide genetic information.</p>
</sec>
<sec>
<title>Discussion</title>
<p>The COMPULS study will offer the unique opportunity to investigate several key aspects of compulsivity across a large cohort of ADHD, ASD and OCD patients.</p>
</sec>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>Compulsivity</kwd>
<kwd>Fronto-striatal circuit</kwd>
<kwd>Glutamate</kwd>
<kwd>ADHD</kwd>
<kwd>ASD</kwd>
<kwd>OCD</kwd>
</kwd-group>
<funding-group>
<award-group>
<funding-source>
<institution-wrap>
<institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100004963</institution-id>
<institution>Seventh Framework Programme</institution>
</institution-wrap>
</funding-source>
<award-id>grant agreement no. 278948</award-id>
<principal-award-recipient>
<name>
<surname>Buitelaar</surname>
<given-names>Jan K.</given-names>
</name>
</principal-award-recipient>
</award-group>
</funding-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2016</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p>Compulsivity and impulsivity are cross-disorder traits that are present across various neurodevelopmental disorders, such as attention-deficit/hyperactivity disorder (ADHD) autism spectrum disorder (ASD) and obsessive compulsive disorder (OCD).</p>
<p>Compulsivity can be defined as the repetitive, irresistible urge to perform certain behaviour, the experience of loss of voluntary control over this intense urge, the diminished ability to delay or inhibit thoughts and behaviours, and the tendency to perform repetitive acts in a habitual or stereotyped manner [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. Compulsivity is a cross-disorder trait observed in the phenotypically distinct neurodevelopmental disorders ASD and OCD. ASDs have a prevalence of 1.5 % [<xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR4">4</xref>] and are characterized by deficits in reciprocal social interaction and communication and by restricted, repetitive and stereotyped patterns of behaviour, interests and activities [<xref ref-type="bibr" rid="CR5">5</xref>]. OCD, on the other hand, is a relatively common anxiety disorder, characterized by repetitive thoughts, impulses, or images (obsessions), and repetitive behaviours or mental acts (compulsions) that cause marked distress [<xref ref-type="bibr" rid="CR5">5</xref>]. OCD has its onset in late childhood and is present in about 2.5 % of the adult population [<xref ref-type="bibr" rid="CR6">6</xref>]. Repetitive behaviours are among the core features of both ASD and OCD, and comparison of symptom characteristics has demonstrated more similarities than differences [<xref ref-type="bibr" rid="CR7">7</xref>]. In addition to symptom overlap, similar executive function impairments related to inhibiting compulsive behaviours have been reported in first degree relatives of people with ASD and OCD [<xref ref-type="bibr" rid="CR8">8</xref>]. Compulsivity can be seen as an overarching concept that includes both the failure to resist an impulse, which links it to impulsivity, and maladaptive habitual patterns of behaviours, which relates to addictive behaviour.</p>
<p>Impulsivity is described as a predisposition toward rapid unplanned reactions to internal or external stimuli with diminished regard to the potentially negative consequences of these reactions [<xref ref-type="bibr" rid="CR2">2</xref>]. Impulsivity is one of the core characteristics of ADHD. ADHD is characterized by clinically significant levels of hyperactivity, impulsivity and/or inattention and is affecting about 5 % of all school-age children world-wide [<xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. About 40 % of children with ADHD have comorbid ASD (e.g. [<xref ref-type="bibr" rid="CR11">11</xref>–<xref ref-type="bibr" rid="CR13">13</xref>]). Further, prevalence of OCD in children with ADHD is estimated at 8 %, which is a 2-3 fold increase compared to non-ADHD children [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR14">14</xref>]. There are strong similarities between the uncontrollable behaviour based on impulsivity (seen in ADHD) and the excessive and unwanted rituals related to compulsivity [<xref ref-type="bibr" rid="CR15">15</xref>].</p>
<p>Addictive behaviour is characterized by both impulsivity and compulsivity [<xref ref-type="bibr" rid="CR16">16</xref>]. One shows compulsive drug-seeking, loss of control in limiting this intake, and the emergence of a negative emotional state reflecting a motivational withdrawal syndrome, when access to the drug is prevented. Impulsivity often dominates early stages of addiction, while compulsivity becomes important in later stages. See Fig. <xref ref-type="fig" rid="Fig1">1</xref> for the relation between compulsivity, impulsivity and addictive behaviour in different disorders.<fig id="Fig1"><label>Fig. 1</label><caption><p>Framework for understanding the relationships between cross-disorder traits impulsivity, compulsivity and addictive behaviours, between discrete disorders, and between traits and disorders by adding a cognitive, neural, genetic and biomarker level of understanding. (ICD, impulse control disorder)</p></caption><graphic id="MO1" xlink:href="12888_2016_1072_Fig1_HTML"></graphic></fig>
</p>
<p>Separate but intercommunicating cortico-striatal circuits seem to be involved in impulsivity and compulsivity [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR17">17</xref>]. In the impulsive circuit, a striatal component (nucleus accumbens) may drive impulsive behaviours, and a prefrontal component (anterior cingulate (ACC), ventromedial prefrontal cortex) exerts inhibitory control. Similarly, compulsive behaviour may be driven by a striatal component (caudate, putamen), which is controlled by the orbitofrontal cortex (OFC). Increased activity in the striatum and/or decreased activity in the prefrontal cortex (PFC) may alter the functioning of these cortico-striatal circuits and cause impulsive or compulsive disorders, both characterized by deficits in response inhibition. Although, in contrast to impulsivity, compulsivity is considered a maladaptive perseveration of behaviour that does not fall within the range of normal behaviour [<xref ref-type="bibr" rid="CR15">15</xref>], both patterns of behaviour often co-occur [<xref ref-type="bibr" rid="CR18">18</xref>, <xref ref-type="bibr" rid="CR19">19</xref>].</p>
<p>Compulsivity-related disorders differ in their age of onset. ASD starts very early in life, ADHD in early childhood, and OCD has its onset in late childhood or early adolescence. This variation in onset of impulsivity/compulsivity may be related to variation in the maturation of the fronto-striatal circuits and the role of glutamate within these circuits. Recent theories suggest that striatal brain regions underlying impulsive and compulsive behaviours may show a nonlinear developmental pattern with a peak inflection between 13 and 17 years of age [<xref ref-type="bibr" rid="CR20">20</xref>]. The prefrontal regions on the other hand, which are important for top-down regulation of (striatum-driven) impulsive and compulsive behaviour, show a more linear pattern of maturation well into young adulthood.</p>
<p>Glutamate is the major excitatory neurotransmitter in the human brain and is critical to the understanding of the top-down control of the prefrontal cortex over the dorsal and ventral striatum [<xref ref-type="bibr" rid="CR21">21</xref>]. The impulsivity- and compulsivity-related fronto-striatal circuits are notable for their relatively rich glutamatergic receptor density. Glutamate modulates the neural activity and metabolism of these circuits, as is reflected by the effects of glutamate on synapse induction and elimination as well as synaptic transmission via ionotropic and metabotropic glutamate receptors [<xref ref-type="bibr" rid="CR22">22</xref>]. Indeed, glutamatergic projections from the prefrontal sub-regions to the striatum are already known to play a key role in various compulsive and impulsive behaviours including repetitive behaviours such as stereotypy seen in ASD, impulsivity seen in ADHD, and feelings of loss of control seen in OCD (for a review, see [<xref ref-type="bibr" rid="CR23">23</xref>]).</p>
<p>The study of genetics offers an opportunity to gather additional evidence for the role of glutamate. Many compulsivity- and impulsivity-related disorders are substantially heritable but genetically very complex, with multiple genetic factors of varying penetrance implicated [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>]. A number of candidate genes have been identified, suggesting glutamatergic pathways to operate in ASD, ADHD, and OCD. For example, variation in genes encoding the glutamate transporters <italic>SLC1A1, SLC1A2,</italic> and <italic>SLC1A3</italic> are strong candidate genes for both ASD and OCD [<xref ref-type="bibr" rid="CR26">26</xref>]. In addition, genes encoding the NMDA receptors <italic>GRIN2A</italic> and <italic>GRIN2B</italic> have been implicated in ASD ([<xref ref-type="bibr" rid="CR27">27</xref>], and <italic>GRIN2B</italic> has also been associated with ADHD [<xref ref-type="bibr" rid="CR28">28</xref>] and OCD [<xref ref-type="bibr" rid="CR29">29</xref>]. While glutamate has an important role in the neurobiology of compulsivity and impulsivity and the related disorders, it is certainly not the only biological substrate involved. For example, we have recently identified central insulin signalling as an additional molecular cascade involved in OCD [<xref ref-type="bibr" rid="CR30">30</xref>] and neurite outgrowth as a neurodevelopmental process implicated in ADHD [<xref ref-type="bibr" rid="CR31">31</xref>] and ASD [<xref ref-type="bibr" rid="CR32">32</xref>]. Genetic variation in such genes is likely to alter their regulation and/or function, leading to changes in the encoded proteins and biological processes contributing to proper cell function. Brain structure and brain function, also highly heritable, may mediate the effects of the variation in genes and proteins on compulsive and impulsive behaviours and related disorders [<xref ref-type="bibr" rid="CR32">32</xref>, <xref ref-type="bibr" rid="CR33">33</xref>]. See Fig. <xref ref-type="fig" rid="Fig2">2</xref> for a representation of this relation between genes, cell functioning, brain and behaviour.<fig id="Fig2"><label>Fig. 2</label><caption><p>Simplified representation of relation between genes, cell functioning, brain functioning and behaviour. Many genes are involved in causing disease symptoms, but reduced numbers of genes are involved in features associated with the disease symptoms, like brain functioning and cell functioning (Adapted from [<xref ref-type="bibr" rid="CR64">64</xref>])</p></caption><graphic id="MO2" xlink:href="12888_2016_1072_Fig2_HTML"></graphic></fig>
</p>
</sec>
<sec id="Sec2">
<title>Methods/Design</title>
<sec id="Sec3">
<title>Aims of the study</title>
<p>COMPULS is a multicenter study as part of the overarching TACTICS study (<ext-link ext-link-type="uri" xlink:href="http://www.tactics-project.eu/">http://www.tactics-project.eu</ext-link>) investigating the relationship between the traits compulsivity, impulsivity, and - to a lesser extent - addictive behaviour within and across the neurodevelopmental disorders ASD, ADHD, and OCD. This will be the first study to integrate these different traits and disorders into one design. The primary objectives are to examine whether these traits are related to structural and functional connectivity of the fronto-striatal circuits and whether these behavioural traits are predicted by or related to abnormal glutamatergic concentrations in these fronto-striatal circuits. Secondary objectives of COMPULS are to explore the role of candidate genes or candidate genetic pathways involved in compulsivity, and related traits within these disorders.</p>
<p>These objectives will be investigated at the phenotypic, cognitive, neural, and genetic level in a prospective longitudinal design. This paper describes the design, measures, and rationale of COMPULS.</p>
</sec>
<sec id="Sec4">
<title>Participants</title>
<p>Data collection occurs at four different sites across Europe (Radboud university medical center and the Donders Institute for Brain, Cognition and Behaviour, Nijmegen, The Netherlands; Brain Centre Rudolf Magnus, University Medical Centre Utrecht, Utrecht, The Netherlands; King’s College London, London, United Kingdom, and Central Institute of Mental Health, Medical Faculty Mannheim, University of Heidelberg Mannheim, Germany). We include 60 participants with ASD, 60 with OCD, 60 with ADHD, and 60 healthy comparison participants in the age range of 8 to 12 years. Every site includes 15 ASD, OCD, and healthy comparison participants (adding up to a total of 60 per group). The ADHD sample is completely collected in Nijmegen. The total sample size consists of 240 participants. Setting alpha at .05 (two-tailed) our sample size of <italic>N</italic> = 240 has 80 % statistical power to detect a beta (standardized regression coefficient) of 0.21. This sample size allows for about 15 covariates/predictors in total. Thus our sample size will provide us sufficient power to establish predictors of small effect size. A group size of 60 participants per group (OCD, ASD, ADHD, controls) further allows us to examine the disease modifying effects in planned contrasts in these regression models (dummy variables).</p>
<p>Inclusion criteria for all groups are age between 8 and 12 years old, IQ &gt; 70, ability to speak and comprehend the native language of the country in which the assessment takes place, and a signed informed consent by parents or legal representatives. For the diagnosis groups, a DSM-IV-TR or DSM-5 diagnosis of the respective disorder has to be present. Exclusion criteria for the ASD, OCD, and ADHD children are diagnoses of the other disorders (comorbidity), e.g. an OCD diagnosis in an ASD participant. Other exclusion criteria include IQ &lt; 70, major physical illness of the vascular, endocrine, pulmonic or the gastrointestinal system, all contra-indications for MR assessment, such as the presence of metal objects in the body (i.e. pacemaker, dental braces), and a history or presence of neurological disorders. For the healthy comparison participants, no first degree family members are allowed to have any psychiatric disorder.</p>
</sec>
<sec id="Sec5">
<title>Measures</title>
<sec id="Sec6">
<title>Diagnosis</title>
<p>To determine the diagnoses several interviews will be administered, depending on the symptoms of the participant. The autism diagnostic interview-revised (ADI-R [<xref ref-type="bibr" rid="CR34">34</xref>]) is a structured developmental interview administered to the parent(s) to assess the symptoms of ASD and make an ASD DSM-IV-TR diagnosis in the child. For an ADHD diagnosis, the semi-structured Kiddie Schedule for Affective Disorders and Schizophrenia (K-SADS [<xref ref-type="bibr" rid="CR35">35</xref>]) will be administered to the parent(s). The Children’s Yale Brown Obsessive Compulsive Scale (CYBOCS [<xref ref-type="bibr" rid="CR36">36</xref>]) is used to interview the parent(s) and child for the presence of obsessions and/or compulsions and symptom severity, when OCD is present. This interview will be performed in all participant groups when screening questions confirm the presence of obsessions or compulsions. In addition, all parents are interviewed using the structured Diagnostic Interview Schedule for Children (DISC [<xref ref-type="bibr" rid="CR37">37</xref>]), the Development and Well-being Assessment (DAWBA [<xref ref-type="bibr" rid="CR38">38</xref>]) or the K-SADS to assess the presence of possible comorbidities such as oppositional defiant disorder, conduct disorder, and the presence of tics/Tourette’s syndrome and anxiety disorders. The diagnostic tools provide operational definitions of individual symptoms as well as diagnosis-relevant questions, such as onset of symptoms and impairment in several areas of life.</p>
</sec>
<sec id="Sec7">
<title>Questionnaires</title>
<p>Questionnaires are used to assess (a) symptom severity of possible comorbid disorders, such as ADHD (Conners’ Parent Rating Scale (CPRS R:L [<xref ref-type="bibr" rid="CR39">39</xref>]) and ASDs (Children’s Social Behavioural Questionnaire (CSBQ [<xref ref-type="bibr" rid="CR40">40</xref>]), (b) Substance use disorders (SUDs; Alcohol Use Disorders Identification Test (AUDIT [<xref ref-type="bibr" rid="CR41">41</xref>]), drug abuse (Drug Abuse Screening Test (DAST [<xref ref-type="bibr" rid="CR42">42</xref>]), and nicotine dependence (Fagerstrøm Test for Nicotine Dependence (FTND [<xref ref-type="bibr" rid="CR43">43</xref>]), (c) lifetime alcohol-related problems (Michigan Alcohol Screening Test (MAST [<xref ref-type="bibr" rid="CR44">44</xref>]), (d) gambling problems (South Oaks Gambling Screen (SOGS [<xref ref-type="bibr" rid="CR45">45</xref>]), (e) repetitive behaviour (Repetitive Behaviour Scale-Revised (RBS-R [<xref ref-type="bibr" rid="CR46">46</xref>]), (f) emotional and behavioural problems (Child Behaviour Check List (CBCL [<xref ref-type="bibr" rid="CR47">47</xref>]); Teacher report form (TRF) [<xref ref-type="bibr" rid="CR47">47</xref>]), and (g) physical development [<xref ref-type="bibr" rid="CR48">48</xref>], to determine the developmental stage at the time of assessment. All questionnaires are completed by the parent(s). A final set of measures is taken to determine patterns of use of prescribed medication (in house self-report for medication use).</p>
</sec>
<sec id="Sec8">
<title>Cognitive assessment</title>
<p>All children complete an extensive protocol of cognitive tasks measuring (a) intellectual functioning estimated from the (i) vocabulary, (ii) block design, (iii) similarities, and (iv) picture completion subtests of the WISC [<xref ref-type="bibr" rid="CR49">49</xref>], (b) motor inhibition, (c) cognitive flexibility, and (d) motor speed. Except for the subtests of the WISC, all tests are computerized. For cognitive flexibility, a timing task will be administered [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. For measuring motor inhibition and motor speed, we will use the set-shifting and baseline-speed tasks of the Amsterdam Neuropsychological Tests (ANT [<xref ref-type="bibr" rid="CR50">50</xref>]).</p>
</sec>
<sec id="Sec9">
<title>MR measurements</title>
<p>Participating children complete a brain scan session in a magnetic resonance imaging (MRI) scanner. At the four different sites, comparable 3 Tesla MRI scanners are used (Siemens Trio and Siemens Prisma, Siemens, Erlangen, Germany; Philips 3 T Achieva, Philips Medical Systems, Best, The Netherlands; General Electric MR750, GE Medical Systems, Milwaukee, WI, USA) using a 32 channel (Siemens) or 8 channel head coil (Philips, GE). A scanning session includes an anatomical T1 scan, resting state functional MRI (R-fMRI), Diffusion Tensor Imaging (DTI), and two functional imaging tasks including a behavioural inhibition (Stop) task [<xref ref-type="bibr" rid="CR51">51</xref>] and a shortened monetary reward anticipation task [<xref ref-type="bibr" rid="CR50">50</xref>, <xref ref-type="bibr" rid="CR51">51</xref>]. COMPULS’ areas of interest are the fronto-striatal circuits, important signalling regions that are undergoing developmental changes in the age range of 8 to 12 years. As described in the introduction, differences exist in the onset of compulsive disorders. In order to capture glutamatergic deficits across these disorders, an MR spectroscopy session with two voxels of interest encompassing a part of these fronto-striatal circuits (left dorsal striatum and ACC) is also included in the MRI session.</p>
<p>The structural T1 scanning sequences are based on the ADNI GO protocols [<xref ref-type="bibr" rid="CR52">52</xref>–<xref ref-type="bibr" rid="CR55">55</xref>] to be matched as closely as possible across the different scanning sites. For R-fMRI we use a multi-echo sequence to be able to separate BOLD from non-BOLD signal more accurately [<xref ref-type="bibr" rid="CR56">56</xref>], DTI acquisition is chosen to better resolve crossing fibers and task-based fMRI acquisition is designed for optimal signal stability and homogeneity over the different sites (see Table <xref ref-type="table" rid="Tab1">1</xref> for an overview of the scan sequences). In order to perform quality assessment of the MR scanning sessions across four different sites, we will make use of phantoms and so-called ‘travelling heads’. By using phantoms, we can assess subtle changes in scanner output over time (due to scanner drifts, system upgrades, etc.), but we feel that this is not sufficient to allow for calibration of human brain data. In order to compare the quality of the human brain scans across sites, the travelling heads are thus used, i.e. three adult volunteers will travel to the four participating sites at the start of COMPULS, at the end of the data collection, and in-between, whenever scanner upgrades are performed. This will allow us to assess inter-scanner reliability and take into account differences between scanners. These travelling head data-sets will additionally be used to compare intra- and inter-site variability with regard to the measurement of glutamate. On-site MRS training will be provided before data-collection to assure similarity in terms of voxel placement across sites.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Scan sequences</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Sequence</th><th>Site</th><th>TR/TE/TI (ms)</th><th>Flip angle</th><th>Field of view (mm)</th><th>Matrix RL/AP/slices</th><th>Voxel-size (mm)</th><th>Gap (%)</th><th>Parallel Imaging</th><th>
<italic>b</italic> value</th><th>Directions/<italic>b</italic>0’s</th><th>Averages Water suppressed/unsuppressed</th></tr></thead><tbody><tr><td>T1</td><td>Nijmegen <italic>(Siemens)</italic>
</td><td>2300<sup>*</sup>/2.98/900</td><td>9</td><td>256</td><td>212/256/176</td><td>1.0 * 1.0 * 1.2</td><td>NA</td><td>2</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td></td><td>Mannheim <italic>(Siemens)</italic>
</td><td>2300<sup>*</sup>/2.98/900</td><td>9</td><td>270</td><td>212/254/176</td><td>1.1 * 1.1 * 1.2</td><td>NA</td><td>2</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td></td><td>Utrecht <italic>(Philips)</italic>
</td><td>6.8<sup>*</sup>/3.10/823</td><td>9</td><td>270</td><td>204/252/170</td><td>1.1 * 1.1 * 1.2</td><td>NA</td><td>1.8</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td></td><td>London <italic>(GE)</italic>
</td><td>7.31<sup>*</sup>/3.02/400</td><td>11</td><td>270</td><td>256/256/196</td><td>1.1 * 1.1 * 1.2</td><td>NA</td><td>1.75</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>MRS<break></break>PRESS</td><td>All</td><td>3000/30/-</td><td>NA</td><td>NA</td><td>NA</td><td>20 * 20* 20</td><td>NA</td><td>NA</td><td>NA</td><td>NA</td><td>96/16</td></tr><tr><td>R-FMRI<sup>#</sup>
</td><td>All</td><td>2300/12<sup>a</sup>–13<sup>b</sup>/-</td><td>80</td><td>240</td><td>240/240/33</td><td>3.8 * 3.8 * 3.8</td><td>11</td><td>2 – 2.5<sup>c</sup>
</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>Functional tasks</td><td>All</td><td>2070/35/-</td><td>74</td><td>192</td><td>192/192/36</td><td>3.0 * 3.0 * 3.0</td><td>13</td><td>2</td><td>NA</td><td>NA</td><td>NA</td></tr><tr><td>DTI</td><td>All</td><td>12000/103/-</td><td>90</td><td>256</td><td>256/256/72</td><td>2.0 * 2.0 * 2.0</td><td>0</td><td>2</td><td>1500</td><td>60/2</td><td>NA</td></tr></tbody></table><table-wrap-foot><p>
<sup>*</sup>As provided by the manufacturer. Philips and GE define a TR as the time an excitation pulse is given, while Siemens defines TR as the time between inversion recovery pulses a volume</p><p>
<sup>#</sup>Multi-echo resting state fMRI: TE2 is 31 ms for London and Utrecht, 29 for Mannheim and 28.41 for Nijmegen. TE3 is 48 for London, 49 for Utrecht, 46 for Mannheim and 44.82 for Nijmegen</p><p>
<sup>a</sup>Nijmegen, Mannheim</p><p>
<sup>b</sup>Utrecht, London</p><p>
<sup>c</sup>Utrecht</p></table-wrap-foot></table-wrap>
</p>
</sec>
<sec id="Sec10">
<title>Genetic determinants</title>
<p>Participants will provide 40 ml blood for DNA-isolation and assessment of biomarkers for which serum and plasma fractions will be prepared. The venapuncture will be performed by a trained practical nurse. If a participant refuses venapuncture, saliva will be used for DNA-isolation instead.</p>
<p>DNA, RNA, and plasma/serum fractions will be isolated from blood/saliva using standard techniques and stored at the department of Human Genetics of the Radboud university medical center. MicroRNAs (miRNA) will be extracted from total RNA isolated from blood collected in PAX-gene tubes. The DNA will be subjected to genome-wide genotyping, providing a basis for the computation of polygenic risk scores; such scores will be incorporated in analyses of disease risk, and might improve phenotypic prediction [<xref ref-type="bibr" rid="CR57">57</xref>]. The current study on itself will have a small sample size and is of course insufficient to detect genome-wide significant effects. However, by aggregation of multiple variants at the level of individual genes or gene-sets through mass-univariate or multivariate methods, power may be increased [<xref ref-type="bibr" rid="CR58">58</xref>–<xref ref-type="bibr" rid="CR60">60</xref>]. This will provide opportunities for candidate gene/pathway analyses, which of course will require appropriate correction for multiple testing. Lastly, by contributing to international collaborations like the Psychiatric Genomics Consortium (PGC; [<xref ref-type="bibr" rid="CR61">61</xref>] and Enhancing Neuro Imaging Genetics through meta-analysis (ENIGMA; [<xref ref-type="bibr" rid="CR62">62</xref>])), our data may contribute to genome-wide gene-finding studies will become more powerful.</p>
<p>Protein and miRNA levels of blood-expressed candidate genes will be monitored. In the case of proteomics, this will involve using multiplex immunoassay profiling of serum. In addition, determination of glutamate, serotonin, and insulin levels will be performed. This work will be performed in the laboratory of Professor Bahn in Cambridge.</p>
</sec>
<sec id="Sec11">
<title>Somatic and other measures</title>
<p>To obtain an estimate of possible abnormal growth or other physiological abnormalities, we measure body length, weight, waist circumference, and ask for the presence of allergies or food restrictions.</p>
</sec>
</sec>
<sec id="Sec12">
<title>Procedures</title>
<sec id="Sec13">
<title>Assessment</title>
<p>After initial contact through information packages (including general project information) sent by post, the parents are phoned to check interest in participation. In case of interest, a brief screening will be conducted to control for possible exclusion criteria. If the child meets the inclusion criteria, a questionnaire package will be sent via regular post, also including informed consent/assent forms and general information about the test-location.</p>
<p>If feasible according to the child’s capability, one testing day is organized covering all assessments. During this day, parents will be assessed with the interview. If screening questions are answered positively, screening will be followed by the full supplementary module of the specific disorder. When applicable, CYBOCS and/or the ADI is administered. Cognitive tests with the child will be administered in a fixed order and - due to the length of the battery - split in two parts, part A and part B. The order of administration of the two parts will be counterbalanced across children. Before participating in the MR session, children will be prepared for scanning using a dummy scanner. In this dummy session, children are presented with MR sounds, the button box needed for task completion, and lying in a tight environment. In addition, time to practice the MR tasks is provided during this dummy session. Should a child (or his/her parent) report anxiety to enter the MR scanner, the session will be ended. The anxiety is monitored by using a visual analogue scale (VAS), a scale from 1 to 10, on which the child, parent, and researcher rate the anxiety (1 means no anxiety and 10 means very high anxiety). If the score is 8 or higher, the scan will not be performed. After the MR assessment, the blood-sample will be taken by trained professionals for biological analyses.</p>
<p>A monetary reward is granted and travel costs will be reimbursed. Children who complete the MR session (or at least the anatomical session) are provided with a picture of their anatomical MR scan. Moreover, all children receive an extra monetary reward, which they can gain during the cognitive assessments (inside or outside the MR scanner), and a short report of their performance on the IQ tests, if requested.</p>
</sec>
<sec id="Sec14">
<title>Follow up</title>
<p>A second wave data collection procedure will be performed after the first with an interval of at least 1 year. The same measurements will be administered, except for the ADI-R interview. These two time-points together can give insights in development during an important phase in life, when the transition from childhood and adolescence takes place. The fronto-striatal circuit undergoes several changes during development [<xref ref-type="bibr" rid="CR63">63</xref>], which we can map longitudinally with this study-design.</p>
</sec>
<sec id="Sec15">
<title>Staff training and supervision</title>
<p>The cognitive testing, diagnostic interview, and MRI scanning are restricted to trained personnel. This includes training in Good Clinical Practice (GCP). For the diagnostic interview, staff members have to attend interview sessions led by a trained interviewer. When practicing interviews, one will be under supervision of a clinician or trained professional. The ADI-R is an interview that requires an official certificate and will only be administered by those officially trained. For the diagnostic interviews quality control meetings will be held to discuss controversial cases and to maintain agreement.</p>
<p>To standardize cognitive testing and neuroimaging sessions as much as possible, written standard operating procedures (SOPs) were developed for administration of cognitive tests and MR assessments. All researchers are trained to administer the test battery using the SOPs and under supervision before they can administer tests on their own. The MRI training consists of practicing to operate the scanner computer, learning security procedures, and monitoring quality of the data (i.e. motion artefacts, spike identification).</p>
</sec>
<sec id="Sec16">
<title>Data management and quality control</title>
<p>Every participant is coded with an anonymous identifier number to separate personal data from scientific data. Data acquisition will be documented in a case report listing all data available for that person. Notes regarding factors that may influence the data (analysis) are provided. Every note, questionnaire, informed consent form, etc. will be kept together in a dossier. All digital data will be stored on the device, on which it is administered (laptops), and then securely uploaded to a central storage server. This server backs-up to tape daily. Researchers at the Radboud university medical center are also obligated to archive raw data on at least two different archiving disks.</p>
<p>All data, except for the MRI data, will be uploaded to a central SQL (Structured Query Language) database. This database meets the acquired safety regulations per participating site, and only assigned researchers will have access across the four sites. Data integrity will be controlled by comparing uploaded data to descriptions in the dossier. For MRI data, quality checks are also performed. T1 anatomical scans are quality-rated on a 4-point scale, MR spectra undergo visual inspection for each participant, and various quantitative parameters are calculated for the functional and diffusion imaging data, such as spatial and temporal signal-to-noise-ratios and realignment parameters.</p>
</sec>
</sec>
</sec>
<sec id="Sec17">
<title>Discussion</title>
<p>The COMPULS database will offer the unique opportunity to study several key aspects of compulsivity in a large cohort of ASD, ADHD, and OCD patients. By assessing neural and cognitive systems during the critical period of transition from childhood to adolescence across disorders, we can investigate stability and changes of neural systems, which seem to be critical in the development of compulsive behaviour. Integrating data from cognitive, neural, and genetic markers linked to compulsivity can largely increase our understanding of neural mechanisms involved in compulsivity and related disorders. Additionally, by using a dimensional approach of compulsive and impulsive behaviour in several different disorder groups, we can find differing and overlapping deficits, which may explain the high comorbidity rates. At the clinical level, this would provide means for identifying children at risk for poor clinical outcome and provide a basis for the development of better treatment strategies that take into account this dimensional nature of neurodevelopmental disorders. COMPULS will contribute its data to meta- and mega-analyses in international initiatives like the Psychiatric Genomics Consortium [<xref ref-type="bibr" rid="CR61">61</xref>] and the ENIGMA Consortium [<xref ref-type="bibr" rid="CR62">62</xref>] and will collaborate with other large international project with a focus on neurodevelopmental disorders (i.e. EU AIMS: <ext-link ext-link-type="uri" xlink:href="http://www.eu-aims.eu/">http://www.eu-aims.eu/</ext-link>).</p>
<p>At the more technical and logistic level, the COMPULS database will provide opportunities to thoroughly investigate the effect of acquiring data at different centers on outcome variables during analyses. It can examine which types of data are most sensitive to the effect of multi-centre collection, and can thus provide input for future multi-center studies. It will form an international scientific resource, which may be accessed by other researchers in the field on request.</p>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>(f)MRI</term>
<def>
<p>(functional) magnetic resonance imaging</p>
</def>
</def-item>
<def-item>
<term>ACC</term>
<def>
<p>Anterior cingulate cortex</p>
</def>
</def-item>
<def-item>
<term>ADHD</term>
<def>
<p>Attention deficit hyperactivity disorder</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p>Autism spectrum disorder</p>
</def>
</def-item>
<def-item>
<term>DSM</term>
<def>
<p>Diagnostic and statistical manual of mental disorders</p>
</def>
</def-item>
<def-item>
<term>DTI</term>
<def>
<p>Diffusion tensor imaging</p>
</def>
</def-item>
<def-item>
<term>MRS</term>
<def>
<p>Magnetic resonance spectroscopy</p>
</def>
</def-item>
<def-item>
<term>OFC</term>
<def>
<p>Orbito-frontal cortex</p>
</def>
</def-item>
<def-item>
<term>PFC</term>
<def>
<p>Prefrontal cortex</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgements</title>
<p>The authors would like to thank The TACTICS Consortium Group, consisting of Jan Buitelaar, Saskia de Ruiter, Jilly Naaijen, Sophie Akkermans, Maarten Mennes, Marcel Zwiers, Shahrzad Ilbegi, Leonie Hennissen, Jeffrey Glennon, Ilse van de Vondervoort, Katarzyna Kapusta, Natalia Bielczyk, Houshang Amiri, Martha Havenith, Barbara Franke, Geert Poelmans, Janita Bralten, Tom Heskes, Elena Sokolova, Perry Groot from Radboud University Medical Center Nijmegen, the Netherlands; Steven Williams, David Lythgoe, Muriel Bruchhage, Iulia Dud from Kings College London, United Kingdom; Ralf Dittmann, Tobias Banaschewski, Daniel Brandeis, Konstantin Mechler, Ruth Berg, Isabella Wolf, Alexander Häge, Sarah Hohmann, Regina Boecker, Matthias Ruff from Central Institute of Mental Health, University of Heidelber, Mannheim, Germany; Rick Dijkhuizen, Erwin Blezer, Kajo van der Marel, Pim Pullens, Wouter Mol, Annette van der Toorn, Willem Otte, Caroline van Heijningen, Sarah Durston, Vincent Mensen, Bob Oranje, René Mandl from University Medical Center Utrecht, Utrecht, the Netherlands; Daphna Joel from Tel Aviv University, Tel Aviv, Israel; John Cryan from University College Cork, Cork City, Ireland; Tracey Petryshen, David Pauls, Mai Saito from Massachusetts General Hospital, Boston, USA; Angelique Heckman from Genoway, Lyon, France; Sabine Bahn from University of Cambridge, Cambridge, United Kingdrom; Ameli Schwalber from Concentris, München, Germany; and Philippe Auby from Lundbeck, Valby, Denmark.</p>
<sec id="FPar1">
<title>Funding</title>
<p>The COMPULS project was supported by funding from the European Community’s Seventh Framework Programme (FP7/2007-2013) TACTICS under grant agreement no. 278948. This paper reflects only the authors’ views, and the European Union is not liable for any use that may be made of the information contained therein. The COMPULS study protocol has not undergone peer-review as part of the larger funding award but was evaluated by regional ethics committees.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar3">
<title>Authors’ contributions</title>
<p>JN drafted and formatted the manuscript. SR, MPZ, JCG, SD, DJL, SCRW, TB, DB, BF and JKB all contributed important intellectual content by critically revising the manuscript. JKB designed the study and obtained funding. All authors have approved the manuscript.</p>
</sec>
<sec id="FPar4">
<title>Competing interests</title>
<p>J. K. Buitelaar has been consultant to/member of advisory board of and/or speaker for Janssen Cilag BV, Eli Lilly, Bristol-Myer Squibb, Shering Plough, UCB, Shire, Novartis and Servier. He is not an employee of any of these companies, nor a stock shareholder of any of these companies. He has no other financial or material support, including expert testimony, patents and royalties. B. Franke received an educational speaking fee from Merz. T. Banaschewski served in an advisory or consultancy role for Actelion, Hexal Pharma, Lilly, Medice, Novartis, Oxford outcomes, PCM scientific, Shire and Viforpharma. He received conference support or speaker’s fee by Medice, Novartis and Shire. He is/has been involved in clinical trials conducted by Shire &amp; Viforpharma. The present work is unrelated to the grants and relationships noted earlier. J. Naaijen, S de Ruiter, M P Zwiers, S Durston, J C Glennon, D J Lythgoe, S C R Williams and D Brandeis do not have any conflicts of interest to report.</p>
</sec>
<sec id="FPar5">
<title>Consent to publish</title>
<p>Not applicable.</p>
</sec>
<sec id="FPar6">
<title>Ethics approval and consent to participate</title>
<p>The study was approved by the regional ethics committee of each site (Nijmegen and Utrecht: Commissie Mensgebonden Onderzoek Regio Arnhem-Nijmegen, 2013, NL nr 42004.091.12; Mannheim: Ethics committee of the Medical Faculty Mannheim, Heidelberg University, 2013, nr 213-616 N-MA; London: NRES Committee London - Camberwell St Giles, 2013, nr: 14/LO/1413). We obtain written informed consent from the parents of all children and oral assent from the children. When children are 12 years old they provide written informed assent themselves in addition to the parents. In case a participant or a parent retracts the consent, all data and samples will be withheld from further use for analysis and removed from the database. This is allowed at any point during the study. Participating families are regularly informed with a newsletter about study progress and resulting publications.</p>
</sec>
</ack>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chamberlain</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Fineberg</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Blackwell</surname>
<given-names>AD</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Sahakian</surname>
<given-names>BJ</given-names>
</name>
</person-group>
<article-title>Motor inhibition and cognitive flexibility in obsessive-compulsive disorder and trichotillomania</article-title>
<source/>Am J Psychiatry
          <year>2006</year>
<volume>163</volume>
<issue>7</issue>
<fpage>1282</fpage>
<lpage>1284</lpage>
<pub-id pub-id-type="doi">10.1176/ajp.2006.163.7.1282</pub-id>
<pub-id pub-id-type="pmid">16816237</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fineberg</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Chamberlain</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Goudriaan</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Vanderschuren</surname>
<given-names>LJ</given-names>
</name>
<name>
<surname>Gillan</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Shekar</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gorwood</surname>
<given-names>PA</given-names>
</name>
<name>
<surname>Voon</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Morein-Zamir</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Denys</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Sahakian</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Moeller</surname>
<given-names>FG</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Potenza</surname>
<given-names>MN</given-names>
</name>
</person-group>
<article-title>New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity</article-title>
<source/>CNS Spectr
          <year>2014</year>
<volume>19</volume>
<issue>1</issue>
<fpage>69</fpage>
<lpage>89</lpage>
<pub-id pub-id-type="doi">10.1017/S1092852913000801</pub-id>
<pub-id pub-id-type="pmid">24512640</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baird</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Simonoff</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pickles</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Chandler</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Loucas</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Meldrum</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Charman</surname>
<given-names>T</given-names>
</name>
</person-group>
<article-title>Prevalence of disorders of the autism spectrum in a population cohort of children in South Thames: the Special Needs and Autism Project (SNAP)</article-title>
<source/>Lancet
          <year>2006</year>
<volume>368</volume>
<issue>9531</issue>
<fpage>210</fpage>
<lpage>215</lpage>
<pub-id pub-id-type="doi">10.1016/S0140-6736(06)69041-7</pub-id>
<pub-id pub-id-type="pmid">16844490</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geschwind</surname>
<given-names>DH</given-names>
</name>
<name>
<surname>State</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Autism 1 Gene hunting in autism spectrum disorder : on the path to precision medicine</article-title>
<source/>Lancet Glob Heal
          <year>2015</year>
<volume>4422</volume>
<issue>15</issue>
<fpage>1</fpage>
<lpage>12</lpage>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<collab>American Psychiatric Association</collab>
</person-group>
<source/>Diagnostic criteria from DSM-IV-TR
          <year>2000</year>
<publisher-loc>Washington, D.C</publisher-loc>
<publisher-name>American Psychiatric Association</publisher-name>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nestadt</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Di</surname>
<given-names>CZ</given-names>
</name>
<name>
<surname>Riddle</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Grados</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Greenberg</surname>
<given-names>BD</given-names>
</name>
<name>
<surname>Fyer</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>McCracken</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Rauch</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Murphy</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Cullen</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pinto</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Knowles</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Piacentini</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pauls</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Bienvenu</surname>
<given-names>OJ</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>KY</given-names>
</name>
<name>
<surname>Samuels</surname>
<given-names>JF</given-names>
</name>
<name>
<surname>Roche</surname>
<given-names>KB</given-names>
</name>
</person-group>
<article-title>Obsessive-compulsive disorder: subclassification based on co-morbidity</article-title>
<source/>Psychol Med
          <year>2009</year>
<volume>39</volume>
<issue>9</issue>
<fpage>1491</fpage>
<lpage>1501</lpage>
<pub-id pub-id-type="doi">10.1017/S0033291708004753</pub-id>
<pub-id pub-id-type="pmid">19046474</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Anholt</surname>
<given-names>GE</given-names>
</name>
<name>
<surname>Cath</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>van Oppen</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Eikelenboom</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Smit</surname>
<given-names>JH</given-names>
</name>
<name>
<surname>van Megen</surname>
<given-names>H</given-names>
</name>
<name>
<surname>van Balkom</surname>
<given-names>AJ</given-names>
</name>
</person-group>
<article-title>Autism and ADHD symptoms in patients with OCD: are they associated with specific OC symptom dimensions or OC symptom severity?</article-title>
<source/>J Autism Dev Disord
          <year>2010</year>
<volume>40</volume>
<issue>5</issue>
<fpage>580</fpage>
<lpage>589</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-009-0922-1</pub-id>
<pub-id pub-id-type="pmid">20039111</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Delorme</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Goussé</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Roy</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Trandafir</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Mathieu</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Mouren-Siméoni</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Betancur</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Leboyer</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Shared executive dysfunctions in unaffected relatives of patients with autism and obsessive-compulsive disorder</article-title>
<source/>Eur Psychiatry
          <year>2007</year>
<volume>22</volume>
<issue>1</issue>
<fpage>32</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1016/j.eurpsy.2006.05.002</pub-id>
<pub-id pub-id-type="pmid">17127035</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polanczyk</surname>
<given-names>G</given-names>
</name>
<name>
<surname>De Lima</surname>
<given-names>MS</given-names>
</name>
<name>
<surname>Horta</surname>
<given-names>BL</given-names>
</name>
<name>
<surname>Biederman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Rohde</surname>
<given-names>LA</given-names>
</name>
</person-group>
<article-title>The worldwide prevalence of ADHD: A systematic review and metaregression analysis</article-title>
<source/>Am J Psychiatry
          <year>2007</year>
<volume>164</volume>
<issue>6</issue>
<fpage>942</fpage>
<lpage>948</lpage>
<pub-id pub-id-type="doi">10.1176/ajp.2007.164.6.942</pub-id>
<pub-id pub-id-type="pmid">17541055</pub-id>
</element-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Asherson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Banaschewski</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Biederman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Ramos-quiroga</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Rohde</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Sonuga-Barke</surname>
<given-names>EJ</given-names>
</name>
<name>
<surname>Tannock</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Attention-deficit/hyperactivity disorder</article-title>
<source/>Nat Rev Dis Prim
          <year>2015</year>
<volume>1</volume>
<issue>1</issue>
<fpage>1</fpage>
<lpage>23</lpage>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nijmeijer</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Minderaa</surname>
<given-names>RB</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Mulligan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hartman</surname>
<given-names>CA</given-names>
</name>
<name>
<surname>Hoekstra</surname>
<given-names>PJ</given-names>
</name>
</person-group>
<article-title>Attention-deficit/hyperactivity disorder and social dysfunctioning</article-title>
<source/>Clin Psychol Rev
          <year>2008</year>
<volume>28</volume>
<issue>4</issue>
<fpage>692</fpage>
<lpage>708</lpage>
<pub-id pub-id-type="doi">10.1016/j.cpr.2007.10.003</pub-id>
<pub-id pub-id-type="pmid">18036711</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reiersen</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Constantino</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Volk</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Todd</surname>
<given-names>RD</given-names>
</name>
</person-group>
<article-title>Autistic traits in a population-based ADHD twin sample</article-title>
<source/>J Child Psychol Psychiatry Allied Discip
          <year>2007</year>
<volume>48</volume>
<issue>5</issue>
<fpage>464</fpage>
<lpage>472</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-7610.2006.01720.x</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Polderman</surname>
<given-names>TJC</given-names>
</name>
<name>
<surname>Hoekstra</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Posthuma</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Larsson</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The co-occurrence of autistic and ADHD dimensions in adults: an etiological study in 17,770 twins</article-title>
<source/>Transl Psychiatry
          <year>2014</year>
<volume>4</volume>
<issue>9</issue>
<fpage>e435</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2014.84</pub-id>
<pub-id pub-id-type="pmid">25180574</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Geller</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Biederman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Frazier</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Coffey</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Bellordre</surname>
<given-names>CA</given-names>
</name>
</person-group>
<article-title>Clinical correlates of obsessive compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings</article-title>
<source/>Depress Anxiety
          <year>2000</year>
<volume>11</volume>
<issue>4</issue>
<fpage>163</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="doi">10.1002/1520-6394(2000)11:4&lt;163::AID-DA3&gt;3.0.CO;2-3</pub-id>
<pub-id pub-id-type="pmid">10945136</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robbins</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Gillan</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>de Wit</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Ersche</surname>
<given-names>KD</given-names>
</name>
</person-group>
<article-title>Neurocognitive endophenotypes of impulsivity and compulsivity: towards dimensional psychiatry</article-title>
<source/>Trends Cogn Sci
          <year>2012</year>
<volume>16</volume>
<issue>1</issue>
<fpage>81</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="doi">10.1016/j.tics.2011.11.009</pub-id>
<pub-id pub-id-type="pmid">22155014</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Koob</surname>
<given-names>GF</given-names>
</name>
<name>
<surname>Le Moal</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Drug abuse: hedonic homeostatic dysregulation</article-title>
<source/>Science
          <year>1997</year>
<volume>278</volume>
<issue>5335</issue>
<fpage>52</fpage>
<lpage>58</lpage>
<pub-id pub-id-type="doi">10.1126/science.278.5335.52</pub-id>
<pub-id pub-id-type="pmid">9311926</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fineberg</surname>
<given-names>NA</given-names>
</name>
<name>
<surname>Potenza</surname>
<given-names>MN</given-names>
</name>
<name>
<surname>Chamberlain</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Berlin</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Menzies</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Bechara</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sahakian</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Robbins</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Bullmore</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Hollander</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Probing compulsive and impulsive behaviors, from animal models to endophenotypes: a narrative review</article-title>
<source/>Neuropsychopharmacology
          <year>2010</year>
<volume>35</volume>
<issue>3</issue>
<fpage>591</fpage>
<lpage>604</lpage>
<pub-id pub-id-type="doi">10.1038/npp.2009.185</pub-id>
<pub-id pub-id-type="pmid">19940844</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Grant</surname>
<given-names>JE</given-names>
</name>
<name>
<surname>Mancebo</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Eisen</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Rasmussen</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>Impulse-control disorders in children and adolescents with obsessive-compulsive disorder</article-title>
<source/>Psychiatry Res
          <year>2010</year>
<volume>175</volume>
<issue>1–2</issue>
<fpage>109</fpage>
<lpage>113</lpage>
<pub-id pub-id-type="doi">10.1016/j.psychres.2009.04.006</pub-id>
<pub-id pub-id-type="pmid">20004481</pub-id>
</element-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hanna</surname>
<given-names>GL</given-names>
</name>
</person-group>
<article-title>Demographic and clinical features of obsessive-compulsive disorder in children and adolescents</article-title>
<source/>J Am Acad Child Adolesc Psychiatry
          <year>1995</year>
<volume>34</volume>
<issue>1</issue>
<fpage>19</fpage>
<lpage>27</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-199501000-00009</pub-id>
<pub-id pub-id-type="pmid">7860451</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Casey</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>RM</given-names>
</name>
</person-group>
<article-title>Neurobiology of the adolescent brain and behavior: Implications for substance use disorders</article-title>
<source/>J Am Acad Child Adolesc Psychiatry
          <year>2010</year>
<volume>49</volume>
<issue>12</issue>
<fpage>1189</fpage>
<lpage>1201</lpage>
<pub-id pub-id-type="pmid">21093769</pub-id>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnsten</surname>
<given-names>AFT</given-names>
</name>
</person-group>
<article-title>Stress signalling pathways that impair prefrontal cortex structure and function</article-title>
<source/>Nat Rev Neurosci
          <year>2009</year>
<volume>10</volume>
<issue>6</issue>
<fpage>410</fpage>
<lpage>422</lpage>
<pub-id pub-id-type="doi">10.1038/nrn2648</pub-id>
<pub-id pub-id-type="pmid">19455173</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pittenger</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Bloch</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>Glutamate abnormalities in obsessive compulsive disorder: neurobiology, pathophysiology, and treatment</article-title>
<source/>Pharmacol Ther
          <year>2011</year>
<volume>132</volume>
<issue>3</issue>
<fpage>314</fpage>
<lpage>332</lpage>
<pub-id pub-id-type="doi">10.1016/j.pharmthera.2011.09.006</pub-id>
<pub-id pub-id-type="pmid">21963369</pub-id>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naaijen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Lythgoe</surname>
<given-names>DJ</given-names>
</name>
<name>
<surname>Amiri</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Glennon</surname>
<given-names>JC</given-names>
</name>
</person-group>
<article-title>Fronto-striatal glutamatergic compounds in compulsive and impulsive syndromes: a review of magnetic resonance spectroscopy studies</article-title>
<source/>Neurosci Biobehav Rev
          <year>2015</year>
<volume>52</volume>
<fpage>74</fpage>
<lpage>88</lpage>
<pub-id pub-id-type="doi">10.1016/j.neubiorev.2015.02.009</pub-id>
<pub-id pub-id-type="pmid">25712432</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ronemus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Wigler</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The role of de novo mutations in the genetics of autism spectrum disorders</article-title>
<source/>Nat Rev Genet
          <year>2014</year>
<volume>15</volume>
<issue>2</issue>
<fpage>133</fpage>
<lpage>141</lpage>
<pub-id pub-id-type="doi">10.1038/nrg3585</pub-id>
<pub-id pub-id-type="pmid">24430941</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Browne</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Gair</surname>
<given-names>SL</given-names>
</name>
<name>
<surname>Scharf</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Grice</surname>
<given-names>DE</given-names>
</name>
</person-group>
<article-title>Genetics of Obsessive-Compulsive Disorder and Related Disorders</article-title>
<source/>Psychiatr Clin North Am
          <year>2014</year>
<volume>37</volume>
<fpage>319</fpage>
<lpage>335</lpage>
<pub-id pub-id-type="doi">10.1016/j.psc.2014.06.002</pub-id>
<pub-id pub-id-type="pmid">25150565</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rotge</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Aouizerate</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Tignol</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bioulac</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Burbaud</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Guehl</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>The glutamate-based genetic immune hypothesis in obsessive-compulsive disorder. An integrative approach from genes to symptoms</article-title>
<source/>Neuroscience
          <year>2010</year>
<volume>165</volume>
<issue>2</issue>
<fpage>408</fpage>
<lpage>417</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroscience.2009.10.043</pub-id>
<pub-id pub-id-type="pmid">19861150</pub-id>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yoo</surname>
<given-names>HJ</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>IH</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>SA</given-names>
</name>
</person-group>
<article-title>Family based association of GRIN2A and GRIN2B with Korean autism spectrum disorders</article-title>
<source/>Neurosci Lett
          <year>2012</year>
<volume>512</volume>
<issue>2</issue>
<fpage>89</fpage>
<lpage>93</lpage>
<pub-id pub-id-type="doi">10.1016/j.neulet.2012.01.061</pub-id>
<pub-id pub-id-type="pmid">22326929</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Dorval</surname>
<given-names>KM</given-names>
</name>
<name>
<surname>Wigg</surname>
<given-names>KG</given-names>
</name>
<name>
<surname>Crosbie</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Tannock</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Ickowicz</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pathare</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Malone</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Schachar</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Barr</surname>
<given-names>CL</given-names>
</name>
</person-group>
<article-title>Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder</article-title>
<source/>Genes Brain Behav
          <year>2007</year>
<volume>6</volume>
<issue>5</issue>
<fpage>444</fpage>
<lpage>452</lpage>
<pub-id pub-id-type="doi">10.1111/j.1601-183X.2006.00273.x</pub-id>
<pub-id pub-id-type="pmid">17010153</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Arnold</surname>
<given-names>PD</given-names>
</name>
<name>
<surname>MacMaster</surname>
<given-names>FP</given-names>
</name>
<name>
<surname>Richter</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Hanna</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Sicard</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Burroughs</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Mirza</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Easter</surname>
<given-names>PC</given-names>
</name>
<name>
<surname>Rose</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Kennedy</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Rosenberg</surname>
<given-names>DR</given-names>
</name>
</person-group>
<article-title>Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive-compulsive disorder</article-title>
<source/>Psychiatry Res - Neuroimaging
          <year>2009</year>
<volume>172</volume>
<issue>2</issue>
<fpage>136</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="doi">10.1016/j.pscychresns.2009.02.005</pub-id>
<pub-id pub-id-type="pmid">19324536</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van de Vondervoort</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Poelmans</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Aschrafi</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Pauls</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Glennon</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>An integrated molecular landscape implicates the regulation of dendritic spine formation through insulin-related signalling in obsessive-compulsive disorder</article-title>
<source/>J Psychiatry Neurosci
          <year>2016</year>
<volume>41</volume>
<issue>4</issue>
<fpage>280</fpage>
<lpage>285</lpage>
<pub-id pub-id-type="doi">10.1503/jpn.140327</pub-id>
<pub-id pub-id-type="pmid">26854754</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poelmans</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Pauls</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>JK</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Integrated genome-wide association study findings: identification of a neurodevelopmental network for attention deficit hyperactivity disorder</article-title>
<source/>Am J Psychiatry
          <year>2011</year>
<volume>168</volume>
<issue>4</issue>
<fpage>365</fpage>
<lpage>377</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2010.10070948</pub-id>
<pub-id pub-id-type="pmid">21324949</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Poelmans</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pauls</surname>
<given-names>DL</given-names>
</name>
<name>
<surname>Glennon</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>JK</given-names>
</name>
</person-group>
<article-title>AKAPs integrate genetic findings for autism spectrum disorders</article-title>
<source/>Transl Psychiatry
          <year>2013</year>
<volume>3</volume>
<fpage>e270</fpage>
<pub-id pub-id-type="doi">10.1038/tp.2013.48</pub-id>
<pub-id pub-id-type="pmid">23756379</pub-id>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Glahn</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Winkler</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Kochunov</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Almasy</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Duggirala</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Carless</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Curran</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Olvera</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Laird</surname>
<given-names>AR</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Beckmann</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>PT</given-names>
</name>
<name>
<surname>Blangero</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Genetic control over the resting brain</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2010</year>
<volume>107</volume>
<issue>3</issue>
<fpage>1223</fpage>
<lpage>1228</lpage>
<pub-id pub-id-type="doi">10.1073/pnas.0909969107</pub-id>
<pub-id pub-id-type="pmid">20133824</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lord</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Rutter</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Couteur</surname>
<given-names>AL</given-names>
</name>
</person-group>
<article-title>Autism diagnostic interview-revised: A revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders</article-title>
<source/>J Autism Dev Disord
          <year>1994</year>
<volume>24</volume>
<issue>5</issue>
<fpage>659</fpage>
<lpage>685</lpage>
<pub-id pub-id-type="doi">10.1007/BF02172145</pub-id>
<pub-id pub-id-type="pmid">7814313</pub-id>
</element-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kaufman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Birmaher</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Brent</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Rao</surname>
<given-names>U</given-names>
</name>
<name>
<surname>Flynn</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Moreci</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Williamson</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ryan</surname>
<given-names>N</given-names>
</name>
</person-group>
<article-title>Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data</article-title>
<source/>J Am Acad Child Adolesc Psychiatry
          <year>1997</year>
<volume>36</volume>
<issue>7</issue>
<fpage>980</fpage>
<lpage>988</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-199707000-00021</pub-id>
<pub-id pub-id-type="pmid">9204677</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Scahill</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dimitropoulos</surname>
<given-names>A</given-names>
</name>
<name>
<surname>McDougle</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Aman</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Feurer</surname>
<given-names>ID</given-names>
</name>
<name>
<surname>McCracken</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Tierney</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>J</given-names>
</name>
<name>
<surname>White</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lecavalier</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hallett</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Bearss</surname>
<given-names>K</given-names>
</name>
<name>
<surname>King</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Arnold</surname>
<given-names>LE</given-names>
</name>
<name>
<surname>Vitiello</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Children’s Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist</article-title>
<source/>J Am Acad Child Adolesc Psychiatry
          <year>2014</year>
<volume>53</volume>
<issue>1</issue>
<fpage>97</fpage>
<lpage>107</lpage>
<pub-id pub-id-type="doi">10.1016/j.jaac.2013.09.018</pub-id>
<pub-id pub-id-type="pmid">24342389</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Shaffer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Fisher</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lucas</surname>
<given-names>CP</given-names>
</name>
<name>
<surname>Dulcan</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Schwab-Stone</surname>
<given-names>ME</given-names>
</name>
</person-group>
<article-title>NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses</article-title>
<source/>J Am Acad Child Adolesc Psychiatry
          <year>2000</year>
<volume>39</volume>
<issue>1</issue>
<fpage>28</fpage>
<lpage>38</lpage>
<pub-id pub-id-type="doi">10.1097/00004583-200001000-00014</pub-id>
<pub-id pub-id-type="pmid">10638065</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goodman</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Ford</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Richards</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Gatward</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>H</given-names>
</name>
</person-group>
<article-title>The Development and Well-Being Assessment: description and initial validation of an integrated assessment of child and adolescent psychopathology</article-title>
<source/>J Child Psychol Psychiatry
          <year>2000</year>
<volume>41</volume>
<issue>5</issue>
<fpage>645</fpage>
<lpage>655</lpage>
<pub-id pub-id-type="doi">10.1111/j.1469-7610.2000.tb02345.x</pub-id>
<pub-id pub-id-type="pmid">10946756</pub-id>
</element-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Conners</surname>
<given-names>CK</given-names>
</name>
<name>
<surname>Sitarenios</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Parker</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Epstein</surname>
<given-names>JN</given-names>
</name>
</person-group>
<article-title>The revised Conners’ Parent Rating Scale (CPRS-R): factor structure, reliability, and criterion validity</article-title>
<source/>J Abnorm Child Psychol
          <year>1998</year>
<volume>26</volume>
<issue>4</issue>
<fpage>257</fpage>
<lpage>268</lpage>
<pub-id pub-id-type="doi">10.1023/A:1022602400621</pub-id>
<pub-id pub-id-type="pmid">9700518</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Luteijn</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Luteijn</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Jackson</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Volkmar</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Minderaa</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The children’s Social Behavior Questionnaire for milder variants of PDD problems: evaluation of the psychometric characteristics</article-title>
<source/>J Autism Dev Disord
          <year>2000</year>
<volume>30</volume>
<issue>4</issue>
<fpage>317</fpage>
<lpage>330</lpage>
<pub-id pub-id-type="doi">10.1023/A:1005527300247</pub-id>
<pub-id pub-id-type="pmid">11039858</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Saunders</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Aasland</surname>
<given-names>OG</given-names>
</name>
<name>
<surname>Babor</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>de la Fuente</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Grant</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II</article-title>
<source/>Addiction
          <year>1993</year>
<volume>88</volume>
<issue>6</issue>
<fpage>791</fpage>
<lpage>804</lpage>
<pub-id pub-id-type="doi">10.1111/j.1360-0443.1993.tb02093.x</pub-id>
<pub-id pub-id-type="pmid">8329970</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gavin</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>Ross</surname>
<given-names>HE</given-names>
</name>
<name>
<surname>Skinner</surname>
<given-names>HA</given-names>
</name>
</person-group>
<article-title>Diagnostic validity of the drug abuse screening test in the assessment of DSM-III drug disorders</article-title>
<source/>Br J Addict
          <year>1989</year>
<volume>84</volume>
<issue>3</issue>
<fpage>301</fpage>
<lpage>307</lpage>
<pub-id pub-id-type="doi">10.1111/j.1360-0443.1989.tb03463.x</pub-id>
<pub-id pub-id-type="pmid">2650770</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heatherton</surname>
<given-names>TF</given-names>
</name>
<name>
<surname>Kozlowski</surname>
<given-names>LT</given-names>
</name>
<name>
<surname>Frecker</surname>
<given-names>RC</given-names>
</name>
<name>
<surname>Fagerstrom</surname>
<given-names>KO</given-names>
</name>
</person-group>
<article-title>The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire</article-title>
<source/>Br J Addict
          <year>1991</year>
<volume>86</volume>
<issue>9</issue>
<fpage>1119</fpage>
<lpage>1127</lpage>
<pub-id pub-id-type="doi">10.1111/j.1360-0443.1991.tb01879.x</pub-id>
<pub-id pub-id-type="pmid">1932883</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Selzer</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Vinokur</surname>
<given-names>A</given-names>
</name>
<name>
<surname>van Rooijen</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>A self-administered Short Michigan Alcoholism Screening Test (SMAST)</article-title>
<source/>J Stud Alcohol
          <year>1975</year>
<volume>36</volume>
<issue>1</issue>
<fpage>117</fpage>
<lpage>126</lpage>
<pub-id pub-id-type="doi">10.15288/jsa.1975.36.117</pub-id>
<pub-id pub-id-type="pmid">238068</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lesieur</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Blume</surname>
<given-names>SB</given-names>
</name>
</person-group>
<article-title>The South Oaks Gambling Screen (SOGS): a new instrument for the identification of pathological gamblers</article-title>
<source/>Am J Psychiatry
          <year>1987</year>
<volume>144</volume>
<issue>9</issue>
<fpage>1184</fpage>
<lpage>1188</lpage>
<pub-id pub-id-type="doi">10.1176/ajp.144.9.1184</pub-id>
<pub-id pub-id-type="pmid">3631315</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lam</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Aman</surname>
<given-names>MG</given-names>
</name>
</person-group>
<article-title>The Repetitive Behavior Scale-Revised: independent validation in individuals with autism spectrum disorders</article-title>
<source/>J Autism Dev Disord
          <year>2007</year>
<volume>37</volume>
<issue>5</issue>
<fpage>855</fpage>
<lpage>866</lpage>
<pub-id pub-id-type="doi">10.1007/s10803-006-0213-z</pub-id>
<pub-id pub-id-type="pmid">17048092</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bordin</surname>
<given-names>IA</given-names>
</name>
<name>
<surname>Rocha</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Paula</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Teixeira</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Achenbach</surname>
<given-names>TM</given-names>
</name>
<name>
<surname>Rescorla</surname>
<given-names>LA</given-names>
</name>
<name>
<surname>Silvares</surname>
<given-names>EF</given-names>
</name>
</person-group>
<article-title>Child Behavior Checklist (CBCL), Youth Self-Report (YSR) and Teacher’s Report Form(TRF): an overview of the development of the original and Brazilian versions</article-title>
<source/>Cad Saude Publica
          <year>2013</year>
<volume>29</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>28</lpage>
<pub-id pub-id-type="doi">10.1590/S0102-311X2013000500004</pub-id>
<pub-id pub-id-type="pmid">23370021</pub-id>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Williams</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Dunlop</surname>
<given-names>LC</given-names>
</name>
</person-group>
<article-title>Pubertal timing and self-reported delinquency among male adolescents</article-title>
<source/>J Adolesc
          <year>1999</year>
<volume>22</volume>
<issue>1</issue>
<fpage>157</fpage>
<lpage>171</lpage>
<pub-id pub-id-type="doi">10.1006/jado.1998.0208</pub-id>
<pub-id pub-id-type="pmid">10066339</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canivez</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Watkins</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>Long-term stability of the Wechsler Intelligence Scale for Children--Third Edition</article-title>
<source/>Psychol Assess
          <year>1998</year>
<volume>10</volume>
<issue>3</issue>
<fpage>285</fpage>
<lpage>291</lpage>
<pub-id pub-id-type="doi">10.1037/1040-3590.10.3.285</pub-id>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<mixed-citation publication-type="other">L. M. de Sonneville. Amsterdam neuropsychological tasks: a computer-aided assessment program. Comput. Psychol. 1999.</mixed-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rubia</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brammer</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Taylor</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Right inferior prefrontal cortex mediates response inhibition while mesial prefrontal cortex is responsible for error detection</article-title>
<source/>Neuroimage
          <year>2003</year>
<volume>20</volume>
<issue>1</issue>
<fpage>351</fpage>
<lpage>358</lpage>
<pub-id pub-id-type="doi">10.1016/S1053-8119(03)00275-1</pub-id>
<pub-id pub-id-type="pmid">14527595</pub-id>
</element-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boecker</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Holz</surname>
<given-names>NE</given-names>
</name>
<name>
<surname>Buchmann</surname>
<given-names>AF</given-names>
</name>
<name>
<surname>Blomeyer</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Plichta</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Baumeister</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Meyer-Lindenberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Banaschewski</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Brandeis</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Laucht</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Impact of early life adversity on reward processing in young adults: EEG-fMRI results from a prospective study over 25 years</article-title>
<source/>PLoS One
          <year>2014</year>
<volume>9</volume>
<issue>8</issue>
<fpage>e104185</fpage>
<pub-id pub-id-type="doi">10.1371/journal.pone.0104185</pub-id>
<pub-id pub-id-type="pmid">25118701</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Plichta</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Wolf</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Hohmann</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baumeister</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Boecker</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schwarz</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Zangl</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Mier</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Diener</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Holz</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Ruf</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Gerchen</surname>
<given-names>MF</given-names>
</name>
<name>
<surname>Bernal-Casas</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Kolev</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Yordanova</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Flor</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Laucht</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Banaschewski</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Kirsch</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Meyer-Lindenberg</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Brandeis</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Simultaneous EEG and fMRI reveals a causally connected subcortical-cortical network during reward anticipation</article-title>
<source/>J Neurosci
          <year>2013</year>
<volume>33</volume>
<issue>36</issue>
<fpage>14526</fpage>
<lpage>14533</lpage>
<pub-id pub-id-type="doi">10.1523/JNEUROSCI.0631-13.2013</pub-id>
<pub-id pub-id-type="pmid">24005303</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jack</surname>
<given-names>CR</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Harvey</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Borowski</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Britson</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Whitwell</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Dale</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Felmlee</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Gunter</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Hill</surname>
<given-names>DLG</given-names>
</name>
<name>
<surname>Killiany</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Schuff</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Fox-Bosetti</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Studholme</surname>
<given-names>C</given-names>
</name>
<name>
<surname>DeCarli</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Krueger</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Ward</surname>
<given-names>HA</given-names>
</name>
<name>
<surname>Metzger</surname>
<given-names>GJ</given-names>
</name>
<name>
<surname>Scott</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Mallozzi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Blezek</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Debbins</surname>
<given-names>JP</given-names>
</name>
<name>
<surname>Fleisher</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Albert</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Green</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Bartzokis</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Glover</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Mugler</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>MW</given-names>
</name>
</person-group>
<article-title>The Alzheimer’s Disease Neuroimaging Initiative (ADNI): MRI methods</article-title>
<source/>J Magn Reson Imaging
          <year>2008</year>
<volume>27</volume>
<issue>4</issue>
<fpage>685</fpage>
<lpage>691</lpage>
<pub-id pub-id-type="doi">10.1002/jmri.21049</pub-id>
<pub-id pub-id-type="pmid">18302232</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jack</surname>
<given-names>CRJ</given-names>
</name>
<name>
<surname>Bernstein</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Borowski</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Gunter</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Fox</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Thompson</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Schuff</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Krueger</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Killiany</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Decarli</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Dale</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Carmichael</surname>
<given-names>OW</given-names>
</name>
<name>
<surname>Tosun</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Weiner</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>Jack</surname>
<given-names>CR</given-names>
<suffix>Jr</suffix>
</name>
</person-group>
<article-title>Update on the magnetic resonance imaging core of the Alzheimer’s disease neuroimaging initiative</article-title>
<source/>Alzheimer’s Dement J Alzheimer’s Assoc
          <year>2010</year>
<volume>6</volume>
<issue>3</issue>
<fpage>212</fpage>
<lpage>220</lpage>
<pub-id pub-id-type="doi">10.1016/j.jalz.2010.03.004</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kundu</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Inati</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Evans</surname>
<given-names>JW</given-names>
</name>
<name>
<surname>Luh</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Bandettini</surname>
<given-names>PA</given-names>
</name>
</person-group>
<article-title>Differentiating BOLD and non-BOLD signals in fMRI time series using multi-echo EPI</article-title>
<source/>Neuroimage
          <year>2012</year>
<volume>60</volume>
<issue>3</issue>
<fpage>1759</fpage>
<lpage>1770</lpage>
<pub-id pub-id-type="doi">10.1016/j.neuroimage.2011.12.028</pub-id>
<pub-id pub-id-type="pmid">22209809</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hamshere</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Langley</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Agha</surname>
<given-names>SS</given-names>
</name>
<name>
<surname>Stergiakouli</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Anney</surname>
<given-names>RJL</given-names>
</name>
<name>
<surname>Buitelaar</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
<name>
<surname>Lesch</surname>
<given-names>KP</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Sonuga-Barke</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Asherson</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Merwood</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kuntsi</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Medland</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Ripke</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Steinhausen</surname>
<given-names>HC</given-names>
</name>
<name>
<surname>Freitag</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Reif</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Renner</surname>
<given-names>TJ</given-names>
</name>
<name>
<surname>Romanos</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Romanos</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Warnke</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Meyer</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Palmason</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vasquez</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Lambregts-Rommelse</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Roeyers</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Biederman</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Doyle</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Hakonarson</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Rothenberger</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Banaschewski</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Oades</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>McGough</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Kent</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Owen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Holmans</surname>
<given-names>P</given-names>
</name>
<name>
<surname>O’Donovan</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Thapar</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>High loading of polygenic risk for ADHD in children with comorbid aggression</article-title>
<source/>Am J Psychiatry
          <year>2013</year>
<volume>170</volume>
<issue>8</issue>
<fpage>909</fpage>
<lpage>916</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2013.12081129</pub-id>
<pub-id pub-id-type="pmid">23599091</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<mixed-citation publication-type="other">Bralten J, Franke B, Waldman I, Rommelse N, Hartman C, Asherson P, Banaschewski T, Ebstein RP, Gill M, Miranda A, Oades RD, Roeyers H, Rothenberger A, Sergeant JA, Oosterlaan J, Sonuga-Barke E, Steinhausen HC, Faraone SV, Buitelaar JK, Arias-Vásquez A. Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD. J Am Acad Child Adolesc Psychiatry. 2013;52:1204–12.</mixed-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bralten</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Arias-Vásquez</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Makkinje</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Veltman</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Brunner</surname>
<given-names>HG</given-names>
</name>
<name>
<surname>Fernández</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Rijpkema</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
</person-group>
<article-title>Association of the Alzheimer’s gene SORL1 with hippocampal volume in young, healthy adults</article-title>
<source/>Am J Psychiatry
          <year>2011</year>
<volume>168</volume>
<issue>10</issue>
<fpage>1083</fpage>
<lpage>1089</lpage>
<pub-id pub-id-type="doi">10.1176/appi.ajp.2011.10101509</pub-id>
<pub-id pub-id-type="pmid">21730226</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Walsh</surname>
<given-names>T</given-names>
</name>
<name>
<surname>McClellan</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>McCarthy</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Addington</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Pierce</surname>
<given-names>SB</given-names>
</name>
<name>
<surname>Cooper</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Nord</surname>
<given-names>AS</given-names>
</name>
<name>
<surname>Kusenda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Malhotra</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Bhandari</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stray</surname>
<given-names>SM</given-names>
</name>
<name>
<surname>Rippey</surname>
<given-names>CF</given-names>
</name>
<name>
<surname>Roccanova</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Makarov</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lakshmi</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Findling</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Sikich</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Stromberg</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Merriman</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Gogtay</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Butler</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Eckstrand</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Noory</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Gochman</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Davis</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EE</given-names>
</name>
<name>
<surname>Meltzer</surname>
<given-names>PS</given-names>
</name>
<name>
<surname>Nelson</surname>
<given-names>SF</given-names>
</name>
<name>
<surname>Singleton</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>MK</given-names>
</name>
<name>
<surname>Rapoport</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>King</surname>
<given-names>MC</given-names>
</name>
<name>
<surname>Sebat</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>Rare structural variants disrupt multiple genes in neurodevelopmental pathways in schizophrenia</article-title>
<source/>Science (80-)
          <year>2008</year>
<volume>320</volume>
<issue>5875</issue>
<fpage>539</fpage>
<lpage>543</lpage>
<pub-id pub-id-type="doi">10.1126/science.1155174</pub-id>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Psychiatric</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Consortium</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Committee</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>A framework for interpreting genome-wide association studies of psychiatric disorders</article-title>
<source/>Mol Psychiatry
          <year>2009</year>
<volume>14</volume>
<issue>1</issue>
<fpage>10</fpage>
<lpage>17</lpage>
<pub-id pub-id-type="doi">10.1038/mp.2008.126</pub-id>
<pub-id pub-id-type="pmid">19002139</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="book">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Stein</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Medland</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Hibar</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Vasquez</surname>
<given-names>AA</given-names>
</name>
<name>
<surname>Renteria</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Toro</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Jahanshad</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Schumann</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Wright</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Martin</surname>
<given-names>NG</given-names>
</name>
<name>
<surname>Agartz</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Alda</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Alhusaini</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Almasy</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Almeida</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Bearden</surname>
<given-names>CE</given-names>
</name>
<name>
<surname>Bergmann</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Binder</surname>
<given-names>EB</given-names>
</name>
<name>
<surname>Blangero</surname>
<given-names>J</given-names>
</name>
</person-group>
<source/>The ENIGMA Consortium : large-scale collaborative analyses of neuroimaging and genetic data
          <year>2014</year>
<fpage>153</fpage>
<lpage>182</lpage>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Somerville</surname>
<given-names>LH</given-names>
</name>
<name>
<surname>Casey</surname>
<given-names>BJ</given-names>
</name>
</person-group>
<article-title>Developmental neurobiology of cognitive control and motivational systems</article-title>
<source/>Curr Opin Neurobiol
          <year>2010</year>
<volume>20</volume>
<issue>2</issue>
<fpage>271</fpage>
<lpage>277</lpage>
<pub-id pub-id-type="doi">10.1016/j.conb.2010.01.006</pub-id>
<pub-id pub-id-type="pmid">20538543</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Franke</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Neale</surname>
<given-names>BM</given-names>
</name>
<name>
<surname>Faraone</surname>
<given-names>SV</given-names>
</name>
</person-group>
<article-title>Genome-wide association studies in ADHD</article-title>
<source/>Hum Genet
          <year>2009</year>
<volume>126</volume>
<issue>1</issue>
<fpage>13</fpage>
<lpage>50</lpage>
<pub-id pub-id-type="doi">10.1007/s00439-009-0663-4</pub-id>
<pub-id pub-id-type="pmid">19384554</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>